The US Environmental Protection Agency (US EPA) continues to drive significant efforts in the United States to modernize the battery of acute toxicity tests classically known as the “6-pack.” Learn More.
Yesterday, the California Senate passed the California Cruelty-Free Cosmetics Act (SB1249) bringing the state one step closer to becoming the first state in the U.S. to ban the sale of animal-tested cosmetics. The bill will now move on to the Assembly. If passed, SB1249 will outlaw the sale of all animal-tested cosmetics (including makeup, hair and skin care, and personal hygiene products) by 2020. Read more.
Our very own Holger Behrsing, PhD, will be presenting at SIVB's Annual Meeting in St. Louis. His presentation on Tuesday, June 5th is titled "Pragmatic Use of State-of-the-Art Lung Models to Evaluate Exposure-induced, Adverse Pulmonary Effects" and will provide an overview of in vitro/ex vivo pulmonary models and how they can be incorporated into a screening/testing strategy for chemicals that can include more complex human pulmonary adverse events that are evaluable in modern 3D systems. Read More
Registration is now open for the 7th Annual ASCCT Meeting - Predictive Toxicology: Strategies for Implementing New Approaches - being held September 11-12, 2018, at the National Institutes of Health in Bethesda, MD. Learn More
The non-binding resolution calls for a diplomatic push towards a global animal testing ban for cosmetics to be in place by 2023. Europe fully banned cosmetic animal testing in 2013, but it is still permitted in 80% of countries worldwide. Read article.
The Humane Society of the United States thanks Governor Ralph Northam for signing a bill to reduce the use of animals in product testing. Virginia is only the fourth state in the country to pass such a law. Delegate Jennifer Boysko, D-86, was the lead patron of the bill, HB 1087. Read article.
The EPA has released a new policy that will allow chemical and pesticide makers to provide the EPA with data from non-animal test methods when assessing for skin allergies. Congratulations to the EPA OPP team for working so hard to put in place this new policy. Read the article here.
IIVS, in collaboration with Philip Morris International, recently presented data highlighting the predictive capability of in vitro assays in determining human response to non-burn tobacco products. Moreover, a ring trial of 6 independent laboratories has generated evidence that key events involved in human disease caused by nicotine-based products can be replicated using non-animal models. These results may increase interest in the use of alternative testing strategies for research and development and, eventually, regulatory acceptance. Read article.
The National Toxicology Program, in collaboration with other US federal agencies, has published a strategic roadmap offering a new framework for the safety testing of drugs & chemicals aimed at reducing the use of animals. Read more.
Recent news articles in the Washington Post and Bloomberg.com highlight China's efforts to move away from requiring animal testing of cosmetics, and the role of IIVS plays in providing much-needed training in alternative methods. Read more about our work in China.